| scholarly article | Q13442814 |
| P2093 | author name string | A S Woolf | |
| G Friedlander | |||
| F Terzi | |||
| P Briand | |||
| E Pillebout | |||
| H T Yuan | |||
| M Burtin | |||
| P2860 | cites work | VEGF(165) mediates glomerular endothelial repair | Q28343621 |
| Mechanisms of angiogenesis and arteriogenesis | Q29617257 | ||
| Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis | Q29617644 | ||
| Pathophysiology of tumor angiogenesis and its relevance in renal cell cancer | Q33655390 | ||
| Role of vascular endothelial growth factor in the regulation of angiogenesis | Q33723796 | ||
| Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia | Q33928113 | ||
| Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. | Q33931625 | ||
| Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders | Q34292807 | ||
| Induction of angiogenesis during the transition from hyperplasia to neoplasia | Q34413571 | ||
| Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury | Q35126310 | ||
| The lack of a functional p21(WAF1/CIP1) gene ameliorates progression to chronic renal failure | Q35632915 | ||
| Angiogenesis in mice with chronic airway inflammation: strain-dependent differences | Q35753515 | ||
| Nature and severity of the glomerular response to nephron reduction is strain-dependent in mice | Q35786298 | ||
| Expression of platelet-derived endothelial cell growth factor and its potential role in up-regulation of angiogenesis in scarred kidneys secondary to urinary tract diseases | Q35788143 | ||
| Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis | Q35788316 | ||
| Morphometry of the renal corpuscle during normal postnatal growth and compensatory hypertrophy. A light microscope study | Q35789974 | ||
| Effect of tissue factor deficiency on mouse and tumor development | Q36243054 | ||
| Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis | Q39784273 | ||
| Reduction of renal mass is lethal in mice lacking vimentin. Role of endothelin-nitric oxide imbalance | Q39790972 | ||
| Progression of renal disease and renal hypertrophy | Q40543219 | ||
| Redistribution of cytoplasmic VEGF to the basolateral aspect of renal tubular cells in ischemia-reperfusion injury | Q40875205 | ||
| Significance of postglomerular capillaries in the pathogenesis of chronic renal failure | Q41184450 | ||
| Early molecular mechanisms in the progression of renal failure: role of growth factors and protooncogenes | Q41743379 | ||
| Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas | Q41866566 | ||
| Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor | Q42768846 | ||
| Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: localization and [125I]VEGF binding sites | Q47989650 | ||
| Peritubular capillary injury during the progression of experimental glomerulonephritis in rats. | Q52537493 | ||
| Renal effect of anti-hypertensive drugs depends on sodium diet in the excision remnant kidney model | Q67560073 | ||
| Glomerular damage after uninephrectomy in young rats. I. Hypertrophy and distortion of capillary architecture | Q68216634 | ||
| Number of interstitial capillary cross-sections assessed by monoclonal antibodies: relation to interstitial damage | Q68381985 | ||
| Expression of vascular endothelial growth factor in renal vascular disease and renal allografts | Q70872964 | ||
| Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats | Q71122486 | ||
| Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases | Q71342515 | ||
| Antitumour effect of a synthetic analogue of fumagillin on murine renal carcinoma | Q71668238 | ||
| Subtotal but not unilateral nephrectomy induces hyperplasia and protooncogene expression | Q71695873 | ||
| Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction | Q71964229 | ||
| Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney | Q72564866 | ||
| Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation | Q73034285 | ||
| Therapeutic intervention in glomerulonephritis by oligonucleotides | Q73236763 | ||
| Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis | Q73499351 | ||
| Subtotal nephrectomy alters tubular function: effect of phosphorus restriction | Q73961032 | ||
| Apoptosis in glomerular endothelial cells during the development of glomerulosclerosis in the remnant-kidney model | Q74835383 | ||
| Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma | Q77804833 | ||
| A potential role for angiotensin II-induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy? | Q77942777 | ||
| The course of the remnant kidney model in mice | Q78016673 | ||
| Expression of angiopoietin-1, angiopoietin-2, and the Tie-2 receptor tyrosine kinase during mouse kidney maturation | Q78124945 | ||
| Sodium restriction decreases AP-1 activation after nephron reduction in the rat: role in the progression of renal lesions | Q95820930 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | CD59b antigen | Q14912244 |
| P304 | page(s) | 547-60 | |
| P577 | publication date | 2001-08-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Proliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesions | |
| P478 | volume | 159 |
| Q36386472 | A transcriptional network underlies susceptibility to kidney disease progression |
| Q85964497 | AKT2 is essential to maintain podocyte viability and function during chronic kidney disease |
| Q46595283 | Angiopoietin-1 therapy enhances fibrosis and inflammation following folic acid-induced acute renal injury. |
| Q34042700 | Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD. |
| Q37892304 | Chronic kidney disease: novel insights from genome-wide association studies |
| Q36553589 | Compensatory renal hypertrophy and the handling of an acute nephrotoxicant in a model of aging. |
| Q28585009 | Dysmorphogenesis of kidney cortical peritubular capillaries in angiopoietin-2-deficient mice |
| Q37078522 | Examining diabetic nephropathy through the lens of mouse genetics |
| Q39375111 | Expression of profibrotic genes in a murine remnant kidney model |
| Q27320632 | Fluorescent microangiography is a novel and widely applicable technique for delineating the renal microvasculature |
| Q41903481 | Galectin-3, a novel centrosome-associated protein, required for epithelial morphogenesis |
| Q37044345 | Genetically altered animal models for Mas and angiotensin-(1-7). |
| Q45071084 | HIF-1alpha expression follows microvascular loss in advanced murine adriamycin nephrosis |
| Q51497691 | Increased urinary lysophosphatidic acid in mouse with subtotal nephrectomy: potential involvement in chronic kidney disease. |
| Q33552200 | Inhibition of tubulointerstitial fibrosis by pentoxifylline is associated with improvement of vascular endothelial growth factor expression |
| Q35919729 | JunD protects against chronic kidney disease by regulating paracrine mitogens. |
| Q34245315 | Lipocalin 2 is essential for chronic kidney disease progression in mice and humans |
| Q37005623 | Long-term High Salt Diet Causes Hypertension and Decreases Renal Expression of Vascular Endothelial Growth Factor in Sprague-Dawley Rats |
| Q36796761 | Maternal environment interacts with modifier genes to influence progression of nephrotic syndrome |
| Q42437368 | Parathyroid hormone-related protein interacts with vascular endothelial growth factor to promote fibrogenesis in the obstructed mouse kidney |
| Q35843371 | Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor-A and hypoxia-inducible factor-1 alpha. |
| Q37053858 | Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease |
| Q44778025 | Plasma protein extravasation and vascular endothelial growth factor expression with endothelial nitric oxide synthase induction in gentamicin-induced acute renal failure in rats |
| Q36144411 | Pleiotropic renal actions of erythropoietin |
| Q38186986 | Potential approaches to reverse or repair renal fibrosis |
| Q35234337 | Progression of glomerular and tubular disease in pediatrics |
| Q36187823 | Relation of peritubular capillary features to class of lupus nephritis |
| Q44921132 | Renal vascular endothelial growth factor in neonatal obstructive nephropathy. I. Endogenous VEGF. |
| Q26743407 | Role of Receptor Tyrosine Kinase Signaling in Renal Fibrosis |
| Q29994848 | Spindle pole cohesion requires glycosylation-mediated localization of NuMA. |
| Q50349533 | Stat3 Controls Tubulointerstitial Communication during CKD. |
| Q34534909 | TGF-alpha mediates genetic susceptibility to chronic kidney disease. |
| Q35996059 | The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer |
Search more.